Brief: OncoZenge Says Positive Stability Results For BupiZenge
01/04/2026 08:22
April 1 (Reuters) - Oncozenge AB ONCOZ.ST: REPORTS POSITIVE STABILITY RESULTS FOR BUPIZENGE AS KEY ENABLER FOR UPCOMING PHASE III TRIAL PHASE III TRIAL FOR BUPIZENGE TO TARGET FIRST PATIENT IN Q2 2026 Source text: ID:nMFN5qsRXG Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))